JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'research area pi3k akt signaling akt'

Search results for: 'research area pi3k akt signaling akt'

A3018 Trametinib (GSK1120212)

7 Citation

Target: MEK

Summary: MEK1 and MEK2 inhibitor, potent and selective

insoluble in H2O; insoluble in EtOH; ≥15.38 mg/mL
A4140 WP1066

Target: STAT|JAK

Summary: JAK2/STAT3 inhibitor,cell-permeable

insoluble in H2O; ≥17.8 mg/mL
A3785 Salinomycin

Target: Antibiotic

Summary: Polyether ionophore antibiotic;anti-cancer
A3016 PLX-4720

1 Citation

Target: Raf

Summary: BRAF kinase inhibitor

≥20.69 mg/mL
A1670 Enzastaurin (LY317615)

2 Citation

Target: PKC

Summary: PKC beta inhibitor,potent and selective

insoluble in EtOH; insoluble in H2O; ≥8.59 mg/mL
A5801 BIX 02189

Target: MEK|ERK

Summary: Selective MEK5 inhibitor

≥22.05 mg/mL
A5803 BIX 02188

Target: MEK

Summary: MEK5 inhibitor,potent and selective

insoluble in H2O; insoluble in EtOH; ≥10.3 mg/mL
A8342 GF 109203X

1 Citation

Target: PKC

Summary: Protein kinase C,MLCK,PKG and PKA inhibitor

insoluble in EtOH; insoluble in H2O; ≥20.6 mg/mL
A3004 Vemurafenib (PLX4032, RG7204)

9 Citation

Target: Raf

Summary: BRAF kinase inhibitor

≥24.5 mg/mL
A2600 (-)-Epigallocatechin gallate (EGCG)

Target: BACE

Summary: Antioxidant, antiangiogenic and antitumor agent

≥22.9 mg/mL